CKC-31929-12813
5 vaccinations
4 coded responses
30 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 483 / MI
- Registered
- 2021-01-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-17
Dose 1 — Pfizer-BioNTech
-
2021-01-18
Registered in v-safe
- 2021-01-18
- 2021-01-19
- 2021-01-22
- 2021-01-23
- 2021-01-24
- 2021-01-31
-
2021-02-07
Dose 2 — Pfizer-BioNTech
-
2021-02-07
Health check-in — day 0, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-08
Survey response — days 1–6 daily, dose 2MedDRA: Injection site coldness, Injection site erythema, Injection site rash, Rash erythematous — Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Chills, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to workFree text: The redness in my arm was from the top of my arm to just above my elbow. It was more like a red rash and that area of my arm felt cold too. As today has progressed it is getting better.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-09
- 2021-02-10
- 2021-02-11
- 2021-02-12
- 2021-02-13
- 2021-02-14
- 2021-02-21
- 2021-02-28
- 2021-03-07
- 2021-03-14
- 2021-03-21
-
2021-05-09
Survey response — 3 months, dose 2MedDRA: Body temperature increased, Cough, Dyspnoea, SARS-CoV-2 test positive, Sinus congestion — Feeling: Fair · Be unable to workFree text: On April 11, 2021 I had cough and sinus congestion. On April 12, had 102 temp. On April 13 went for COVID test, it came back positive. I had trouble breathing for a few days and had to sleep in a recliner, couldnt lay down.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-08-08
-
2021-08-27
Dose 3 — Pfizer-BioNTech
- 2022-02-07
-
2022-05-31
Dose 4 — Pfizer-BioNTech
- 2022-06-15
- 2022-06-21
- 2022-06-28
- 2022-07-05
- 2022-07-12
- 2022-08-30
-
2022-10-15
Dose 5 — Pfizer-BioNTech
-
2022-11-29
Survey response — 6 months, dose 4MedDRA: Fatigue — Feeling: FairFree text: FatigueMedDRA releases: 2024-11 · check-in free text available
-
2023-04-17
Survey response — 6 months, dose 5MedDRA: Fatigue, Oropharyngeal pain, SARS-CoV-2 test positive — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-04-17
Report sent to call center — 6 months, dose 5Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-04-18
-
2023-04-18
Call successfulCompleted over the phone
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-17 | Pfizer-BioNTech | |
| 2 | 2021-02-07 | Pfizer-BioNTech | |
| 3 | 2021-08-27 | Pfizer-BioNTech | No |
| 4 | 2022-05-31 | Pfizer-BioNTech | No |
| 5 | 2022-10-15 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
VAERS report filed, before or during a call: 1
Free text
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): The redness in my arm was from the top of my arm to just above my elbow. It was more like a red rash and that area of my arm felt cold too. As today has progressed it is getting better.
Release 8 — 3 months, dose 2
Symptoms: On April 11, 2021 I had cough and sinus congestion. On April 12, had 102 temp. On April 13 went for COVID test, it came back positive. I had trouble breathing for a few days and had to sleep in a recliner, couldnt lay down.
Release 12 — 6 months, dose 4
Symptoms: Fatigue
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Body temperature increased | ✓ | ✓ | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | SARS-CoV-2 test positive | ✓ | ✓ | ✓ |
| SD | Sinus congestion | ✓ | ✓ | ✓ |
| SRO | Injection site coldness | ✓ | ✓ | ✓ |
| SRO | Injection site erythema | ✓ | ✓ | ✓ |
| SRO | Injection site rash | ✓ | ✓ | ✓ |
| SRO | Rash erythematous | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release